Enovis introduces DynaNail Helix for hindfoot fusions

The DynaNail Helix’s threads allow for easy insertion like a screw. But it also has the dynamic compressive power and stability of a nail. [Image courtesy of Enovis]Enovis Corp. (NYSE: ENOV) has launched the DynaNail Helix —the latest addition to its DynaNail family and suite of foot and ankle products.

As with other DynaNail systems, DynaNail Helix uses proprietary, nitinol-based materials technology. The NiTiNOL tech provides sustained dynamic compression properties for subtalar fusion.

At the same time, Enovis sought to give it an anatomically friendly design and simple, screw-like insertion. As a result, the Helix’s threads also allow for easy insertion like a screw while also providing a nail’s dynamic compressive power and stability.

“It provides sustained compression across the fusion site, which traditional screws cannot do,” said Dr. Christopher Hirose, a foot and ankle orthopedic surgeon based in Boise, Idaho.

Hirose added in the Enov…

Read more
  • 0

Enovis stock dips as it beats The Street in Q3, tightens guidance range

Enovis (NYSE:ENOV) shares took a hit today on third-quarter results that came in ahead of the consensus forecast.

Shares of ENOV dipped 3.4% at $47.89 apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose by 1%.

The Wilmington, Delaware-based company posted losses of $66.5 million for the quarter. That amounts to $1.22 per share on sales of $383.8 million for the three months ended Sept. 30, 2022.

Enovis, the parent company of DJO, recorded a big bottom-line slide into the red on sales growth of 6.6%. The company’s reconstructive segment drove growth with a 15% year-over-year improvement. Ongoing cost inflation provided a negative impact, the company said.

Adjusted to exclude one-time items, earnings per share totaled 59¢. That registered 9¢ ahead of Wall Street. Sales topped analyst expectations, too, as they projected $381.2 million. Read more

  • 0

Enovis makes pair of business unit leadership changes

[Image from Enovis]Enovis (NYSE:ENOV) announced that it appointed Terry Ross and Guy Guglielmino to new leadership roles within the company.

Wilmington, Delaware–based Enovis — the parent company of DJO — says the appointments help to drive its growth.

The company named Ross, who currently serves as president of Enovis recovery sciences, as the president of Enovis bracing & supports. Guglielmino, currently VP of marketing for bracing & supports, assumes Ross’ former role of president of recovery sciences.

Ross holds more than 10 years of experience with Enovis (previously Colfax) in general management, investor relations and business development. He served as president of recovery sciences since 2019. Previous roles include time spent at Danaher and GE.

Guglielmino joined Enovis in 2021 from Wright Medical. At Wright, he led global marketing and medical education for the company’s lower extremities business. He also served as VP o…

Read more
  • 0

Enovis opens new manufacturing plant in Austin

[Image from Enovis]Enovis (NYSE:ENOV) announced that it opened a state-of-the-art manufacturing facility in Austin, Texas last week.

The company held a ribbon-cutting ceremony for the facility’s opening on Sept. 27. President of Enovis Surgical, Louis Vogt, and VP of Operations, Shayne Myhand, attended the event. The 40,000-square-foot ISO 9001-certified center complements Enovis’ existing 75,000-square-foot manufacturing facility.

Wilmington, Delaware-based Enovis said the new facility allos it to employ an additional 100 team members. It expects the plant to support increased demand for its reconstructive hip, knee and shoulder implants.

Enovis said new roles at the facility center around distribution support, metal finishing, CNC machining and clean room operations. The company currently employs more than 5,000 people across the world. Earlier this year, the company launched the ARVIS FDA-cleared augmented reality surgical guidance system. Read more

  • 0

Enovis more than doubles earnings in Q2, scales back EPS guidance

Enovis (NYSE: ENOV) today reported Q2 results that beat The Street on earnings but missed on revenue, with the ortho device company joining the host of medtech companies scaling back earnings projections for the year amid macroeconomic headwinds.

Wilmington, Delaware–based Enovis — the parent company of DJO — earned $121 million, or $2.21 per diluted share, off $395 million in sales for the three months ended July 1, 2022, more than doubling its earnings and growing the top line 11% compared with Q2 2021.

Adjusted to exclude one-time items, Enovis saw earnings per share of 59¢, 9¢ ahead of The Street, where analysts expected sales of $400.97 million.

“We again achieved faster growth than our markets this quarter in both of our business segments,” Enovis CEO Matt Trerotola said ina. news release. “We are executing our strategic priorities, investing in innovation and acquisitions to support our goal to achieve a sustainable high-single-digit organic growt…

Read more
  • 0

The 10 largest orthopedic device companies in the world

Stryker, Johnson & Johnson’s DePuy Synthes and Zimmer Biomet top the list of largest orthopedic device companies. [Adobe Stock image]With elective procedure numbers rebounded after the darkest days of the COVID-19 pandemic, most of the world’s largest orthopedic device companies saw their revenues increase by double-digit percentages during their most recent fiscal years.

Here are the world’s 10 largest orthopedic device companies, ranked by ortho business revenue pulled from their most recent annual reports:

Largest orthopedic device companies Annual revenue (% change) Headquarters 1 Stryker $17.1 billion (+19.2%) Kalamazoo, Michigan 2 Johnson & Johnson – DePuy Synthes $8.6 billion (+10.6%) Locations: Raynham, Massachusetts.; West Chester, Pennsylvania; Warsaw, Indiana; Palm Beach Gardens, Florida 3 Zimmer Biomet (minus ZimVie spinoff) $6.8 billion (+11.6%) Warsaw, Indiana 4 Medtronic – Cranial & Spinal Technologies $4.5 billion (+3.9%) Locat…
Read more
  • 0

Enovis launches augmented reality surgical guidance system

The next-gen Augmented Reality Visualization and Information System (ARVIS) [Image courtesy of Insight Medical Systems/Enovis]Enovis (NYSE:ENOV) announced today that it began the commercial launch of the Arvis (augmented reality visualization and information system).

Wilmington, Delaware-based Enovis — the parent company of DJO Global — earlier this month completed the acquisition of Insight Medical and its Arvis FDA-cleared augmented reality platform for hip and knee replacement surgery.

According to a news release, Arvis is the only proprietary, real-time, hands-free augmented reality (AR) technology precisely engineered for orthopedic surgeons to visualize precision guidance when performing hip and knee surgery with the support of AR.

The self-contained, wearable surgical guidance device can be worn on a headband or with helmets already worn during surgery. It was designed to ensure surgeons can focus on their patient, rather than a screen across the roo…

Read more
  • 0

Enovis completes Insight Medical acquisition

The next-gen Augmented Reality Visualization and Information System (ARVIS) [Image courtesy of Insight Medical Systems]Enovis (NYSE:ENOV) announced today that it acquired orthopedic surgical guidance company Insight Medical Systems.

Wilmington, Delaware-based Enovis — the parent company of DJO Global — did not disclose financial terms for the acquisition of Insight, which develops its flagship Arvis FDA-cleared augmented reality platform for hip and knee replacement surgery.

In March 2021, DJO as part of Enovis made a strategic investment in Insight Medical Systems and its Arvis (augmented reality visualization and information system) for orthopedic surgeries. A previous investment had been made in 2020 and, since that point, Arvis has received FDA 510(k) clearance and successfully completed more than 200 cases in the U.S.

“We are excited to welcome Insight’s talented team to our Enovis family where we will work together to improve patient outcomes through …

Read more
  • 0

Enovis partners with Kelvi on hot and cold therapies

Enovis, the parent company of DJO, announced that it entered into a strategic partnership with Kelvi for heating and cooling therapies.

Kelvi, which develops hot and cold therapy products, will work with Enovis to deliver industry-leading therapies for rehabilitation, recovery and performance enhancement to patients and athletes of all abilities. According to a news release, DJO (as part of Enovis) will become the exclusive distributor in the orthopedic market of Kelvi’s heating and cooling therapy products.

Offering a multimodal approach to heating and cooling, Kelvi develops “smart” KelviTEC technology that applies principles of heating and cooling for medical and athletic recovery while also providing convenience for athletes, athletic trainers and medical technicians, coupled with high precision, tight temperature control, trackability and repeatability, Enovis said.

“As we expand and grow as a med-tech company, we are excited about the i…

Read more
  • 0

DJO parent Enovis unveils Arsenal ankle plating system

Enovis’ Arsenal ankle plating system. [Image from Enovis]Enovis, the parent company of DJO, announced today that it launched its Arsenal ankle plating system.

The Arsenal ankle plating system — the latest addition to the Enovis suite of foot and ankle products and an expansion of the Arsenal foot plating system, consists of 37 anatomically designed plates throughout nine plate families to accommodate any ankle fracture.

According to a news release, the Arsenal system offers variable angle locking technology designed to allow a 60° cone of angulation, multi-lock functionality, accepting repeatable lock and relock of screw to plate interface, and dual lead screws. Enovis said it makes for a “powerful combination” of patented and innovative solutions addressing a number of types of fracture personalities.

Dr. Matthew Herring, a Redding, California-based orthopedic surgery specialist, said in the release that the plates “are stout where …

Read more
  • 0

DJO’s Enovis buys orthopedic bracing assets of Outcome-Based Technologies

Excyabir hip brace and CryoKnee knee brace [Images courtesy of Outcome-Based Technologies]Enovis recently announced that its subsidiary DJO Global acquired the assets of Outcome-Based Technologies hip and knee bracing portfolio.

DJO added the Excyabir hip brace and CryoKnee knee braces to its DonJoy bracing brand.

“The acquisition of the Excyabir hip brace and the CryoKnee knee brace provides innovative bracing solutions to healthcare providers and patients alike,” said Jason Anderson, president of bracing and supports. “We are pleased to welcome Excyabir and CryoKnee to the DonJoy brand. We are confident these products will help grow our bracing business.”

Get the full story on our sister site, Medical Design & Outsourcing.

Read more
  • 0

DJO’s Enovis buys orthopedic bracing assets of Outcome-Based Technologies

Excyabir hip brace and CryoKnee knee brace [Images courtesy of Outcome-Based Technologies]

Enovis recently announced that its subsidiary DJO Global acquired the assets of Outcome-Based Technologies hip and knee bracing portfolio.

DJO added the Excyabir hip brace and CryoKnee knee braces to its DonJoy bracing brand.

“The acquisition of the Excyabir hip brace and the CryoKnee knee brace provides innovative bracing solutions to healthcare providers and patients alike,” said Jason Anderson, president of bracing and supports. “We are pleased to welcome Excyabir and CryoKnee to the DonJoy brand. We are confident these products will help grow our bracing business.”

Outcome-Based Technologies designed Excyabir to increase patient compliance using a lower-profile design. It is a hip brace used in post-op hip arthroscopy, hip osteoarthritis, post-op total hip replacement and other procedures. The wearable d…

Read more
  • 0